News
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...
"Getting out the shower, I felt a tiny spot as I moisturized by body. I trusted my gut and went to get it checked out. I never could have imagined what happened next." ...
Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to ...
A new study has revealed that the drug called pembrolizumab, sold under the brand name Keytruda, not only kept head and neck ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
Nicole Golbari, a dermatological surgeon in Garden City, has a special connection with her patients because she was diagnosed ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ...
1d
Belfast Live on MSN'I used sunbeds from the age of 14 - now I'm 45 with incurable cancer'"I went to a salon in Belfast every week in the summer and I even hired a sunbed to use in my house when I was 18" ...
It was after a climbing fall that Geoff Sweeney first noticed the lump. A keen boulderer, the 53-year-old was scaling a ...
RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results